A new generation of targeted treatments and gentler chemotherapy options for older adults with a new diagnosis of acute myeloid leukemia (AML) is driving better survival and cure rates. Led by Mikkael ...

A new generation of targeted treatments and gentler chemotherapy options for older adults with a new diagnosis of acute myeloid leukemia (AML) is driving better survival and cure rates. Led by Mikkael ...

The amount of noise The Row’s annual sample sale generated last weekend was perhaps antithetical to the brand’s ultimate quiet luxury status. But what else could be expected? The brand’s legions of ...

Panelists discuss how the pathophysiology of acute myeloid leukemia has evolved from a single phenotype understanding to recognizing diverse genetic events that lead to transformation at the ...

Cryptocurrency anti-money laundering (AML) specialist Notabene has introduced Notabene Flow, a stablecoin payment platform designed for high-value business transactions. Notabene, a firm focused on ...

Discover white-collar crime, its types, and real-world examples such as securities fraud and money laundering, with cases ...

In 1969, a now-iconic commercial first popped the question, “How many licks does it take to get to the Tootsie Roll center of a Tootsie Pop?” This deceptively simple line in a 30-second script managed ...

Adding magrolimab to venetoclax and azacitidine did not improve overall survival or complete remission rates in patients with previously untreated acute myeloid leukemia (AML) who were ineligible for ...

NEW YORK--(BUSINESS WIRE)--MCO (MyComplianceOffice), a leading provider of compliance technology, has enhanced its platform with Anti-Money Laundering (AML) and Know-Your-Customer (KYC) capabilities.

At the European Hematology Association (EHA) 2025 Congress, Ashley Yocum, PhD, highlights how the Beat AML Master Trial advances safe, personalized treatment and expands targeted therapy options for ...

An international study led by the University of Colorado Cancer Center has uncovered why a widely used treatment for acute myeloid leukemia (AML) doesn't work for everyone. The findings could help ...